Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy

p300/CBP dependent hyperacetylation of histone potentiates anticancer activity of gefitinib nanoparticles

(2013) Jasmine Kaur et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel

(2013) Guoying Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Establishment of a Paclitaxel Resistant Human Breast Cancer Cell Strain (MCF-7/Taxol) and Intracellular Paclitaxel Binding Protein Analysis

(2013) K-Q Zuo et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation

(2012) RANJITH K AVERINENI et al.   BULLETIN OF MATERIALS SCIENCE

Nanocarrier based formulation of Thymoquinone improves oral delivery: Stability assessment, in vitro and in vivo studies

(2012) Anjali Singh et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer

(2012) Fadwa Odeh et al.   DRUG DELIVERY

Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study

(2012) Sanjar Alam et al.   International Journal of Nanomedicine

Nanoparticle Delivery of Cancer Drugs

(2011) Andrew Z. Wang et al.   Annual Review of Medicine

Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo

(2011) Xiaofei Lei et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anticancer activity of thymoquinone in breast cancer cells: Possible involvement of PPAR-γ pathway

(2011) Chern Chiuh Woo et al.   BIOCHEMICAL PHARMACOLOGY

Thymoquinone: Potential cure for inflammatory disorders and cancer

(2011) Chern Chiuh Woo et al.   BIOCHEMICAL PHARMACOLOGY

New insights into mechanisms of resistance to microtubule inhibitors

(2011) Anutosh Ganguly et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Coformulation of Doxorubicin and Curcumin in Poly(d,l-lactide-co-glycolide) Nanoparticles Suppresses the Development of Multidrug Resistance in K562 Cells

(2011) Ranjita Misra et al.   MOLECULAR PHARMACEUTICS

Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging

(2011) Suphiya Parveen et al.   Nanomedicine-Nanotechnology Biology and Medicine

In vivo Toxicity and Bioavailability of Taxol® and a Paclitaxel/β-Cyclodextrin Formulation in a Rat Model During HIPEC

(2010) W. Bouquet et al.   ANNALS OF SURGICAL ONCOLOGY

RETRACTED: Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential

(2010) Jayaraj Ravindran et al.   BIOCHEMICAL PHARMACOLOGY

Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method

(2010) T.-C. Chou   CANCER RESEARCH

Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo

(2010) Syed H Jafri et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells

(2010) El-Shaimaa A. Arafa et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer

(2010) Sanjeev Banerjee et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling

(2009) Nahed El-Najjar et al.   APOPTOSIS

Antitumor Activity of Gemcitabine and Oxaliplatin Is Augmented by Thymoquinone in Pancreatic Cancer

(2009) Sanjeev Banerjee et al.   CANCER RESEARCH

Anti-tumor activity of paclitaxel-loaded chitosan nanoparticles: An in vitro study

(2009) Fang Li et al.   Materials Science & Engineering C-Materials for Biological Applications

Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells

(2009) Srinivas Ganta et al.   MOLECULAR PHARMACEUTICS

Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity

(2008) Luisa Vicari et al.   BMC CANCER

Thymoquinone Triggers Inactivation of the Stress Response Pathway Sensor CHEK1 and Contributes to Apoptosis in Colorectal Cancer Cells

(2008) H. Gali-Muhtasib et al.   CANCER RESEARCH

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation

(2008) Fabienne Danhier et al.   JOURNAL OF CONTROLLED RELEASE

Targeting Nuclear Factor- B Activation Pathway by Thymoquinone: Role in Suppression of Antiapoptotic Gene Products and Enhancement of Apoptosis

(2008) G. Sethi et al.   MOLECULAR CANCER RESEARCH

Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways

(2008) T. Yi et al.   MOLECULAR CANCER THERAPEUTICS